Linezolid Aurobindo (Linezolid)

Linezolid is an oxazolidinone antibiotic indicated for infections caused by susceptible Gram‑positive bacteria. It is employed in the following clinical situations:

• Gram‑positive bacterial infections: provides bacteriostatic activity against a broad range of resistant strains.
• Methicillin‑resistant Staphylococcus aureus (MRSA): effective for skin, soft‑tissue and invasive infections.
• Community‑acquired pneumonia: used when typical first‑line agents are contraindicated or ineffective.
• Skin and soft tissue infections: treats cellulitis, abscesses, and wound infections caused by susceptible organisms.

• Linezolid inhibits bacterial protein synthesis by binding to the 23S rRNA of the 50S ribosomal subunit. This binding prevents the formation of the initiation complex, halting translation and thereby exerting a bacteriostatic effect against susceptible Gram‑positive organisms.

Adverse reactions may occur with linezolid therapy and are categorized by frequency.

Common Side Effects

• Nausea: mild to moderate gastrointestinal upset.
• Diarrhea: loose stools, often self‑limiting.
• Headache: transient cranial discomfort.
• Vomiting: occasional emesis.
• Metallic taste: altered taste perception.
• Rash: mild skin erythema.

Serious or Rare Side Effects

• Thrombocytopenia: significant drop in platelet count.
• Anemia: reduced hemoglobin levels.
• Peripheral neuropathy: sensory disturbances, potentially irreversible.
• Serotonin syndrome: risk when combined with serotonergic agents.
• Lactic acidosis: metabolic disturbance requiring urgent care.
• Optic neuropathy: visual changes, may be permanent.

Before initiating linezolid, clinicians should consider several safety measures.

• Renal impairment: monitor renal function and adjust therapy as needed.
• Hepatic dysfunction: assess liver enzymes periodically.
• Hematologic monitoring: perform baseline and regular CBC to detect cytopenias.
• Concomitant serotonergic drugs: avoid or monitor closely for serotonin syndrome.
• Hypersensitivity: discontinue if allergic reactions develop.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Linezolid may interact with several drug classes, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

• Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis.
• Selective serotonin reuptake inhibitors (SSRIs) and other serotonergic agents: potential serotonin syndrome.
• Rifampin: may reduce linezolid plasma concentrations.

Moderate Interactions (Monitor Closely)

• Warfarin: may enhance anticoagulant effect, monitor INR.
• Phenytoin and carbamazepine: enzyme inducers that can lower linezolid levels.
• Oral contraceptives: possible reduction in efficacy, advise alternative contraception.
• Non‑steroidal anti‑inflammatory drugs (NSAIDs): increased bleeding risk, monitor closely.